Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT00290810 · COMPLETED
Trial details
- NCT number
- NCT00290810
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2008-10-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.